Behcet's Syndrome Clinical Trial
— SCL90-ROfficial title:
Comparison of Psychological Symptoms in Patients With Behcet's Disease and Control Patients by Symptom Check List 90-Revised (SCL-90-R)
| Verified date | August 2010 |
| Source | Tehran University of Medical Sciences |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Iran: Ethics Committee |
| Study type | Observational |
To find the overall psychological profile of patients with Behcet's Disease (BD) and compare it with Non-BD patients.patients were checked for psychological symptoms by Symptom Check List 90 Revised (SCL90-R)
| Status | Completed |
| Enrollment | 400 |
| Est. completion date | December 2007 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 14 Years and older |
| Eligibility |
Inclusion Criteria: - Behcet's disease patients that their diagnosis was based on the new International Criteria for Behcet's Disease (ICBD). - Non-Behcet's disease patients were patients mimicking BD. Exclusion Criteria: - Probable Behcet's Disease |
Observational Model: Case Control, Time Perspective: Cross-Sectional
| Country | Name | City | State |
|---|---|---|---|
| Iran, Islamic Republic of | Rheumatology Research Center, Shariati Hospital | Tehran |
| Lead Sponsor | Collaborator |
|---|---|
| Tehran University of Medical Sciences |
Iran, Islamic Republic of,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Secondary | Total score of SCL90-R dimensions and global indexes | 22months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00001865 -
HAT in Eye Complications of Behcet's Disease
|
Phase 2 | |
| Terminated |
NCT00550498 -
Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
|
Phase 1 | |
| Completed |
NCT00700297 -
Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
|
Phase 2 | |
| Completed |
NCT00664599 -
Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease
|
Phase 2 |